Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$2.8 - $3.72 $63,344 - $84,157
-22,623 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$2.61 - $4.17 $59,046 - $94,337
22,623 New
22,623 $75,000
Q4 2020

Feb 12, 2021

SELL
$2.15 - $3.5 $558,952 - $909,923
-259,978 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$2.77 - $6.17 $720,139 - $1.6 Million
259,978 New
259,978 $743,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.